• Explore /
  • Poster
  • / Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study.

Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study.

Abstract Poster

Authors

null

Aiwu He

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center

Aiwu He , Benjamin R. Tan , Thatthan Suksombooncharoen , Hidenori Takahashi , Ming-Huang Chen , Vikas S Ostwal , Sang Cheul Oh , Emel Sezer , Piotr Potemski , Kun-Ming Rau , Ekaphop Sirachainan , Junhe Li , Jean-Frédéric Blanc , Gordon Cohen , Magdalena Żotkiewicz , Nana Rokutanda , Do-Youn Oh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03875235

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 550)

DOI

10.1200/JCO.2023.41.4_suppl.550

Abstract #

550

Poster Bd #

D2

Abstract Disclosures

Similar Posters

First Author: Mohamed Bouattour

First Author: Arndt Vogel

First Author: Howard A. Burris III

First Author: Raed Moh'd Taiseer Al-Rajabi